Overview
- Health authorities report roughly 4,200 confirmed cases and about 1,900 deaths, a surge the WHO says began in February 2026 before the outbreak was officially declared in May.
- The outbreak involves the uncommon Bundibugyo Ebola virus for which no approved strain-specific vaccine or therapy exists, and early testing focused on the Zaire strain contributed to diagnostic delays.
- Operational failures are widespread: armed conflict, unpaid health-worker protests, poor contact tracing with 60–75% of new cases found outside monitored lists, and many patients dying in their communities before reaching care.
- WHO and Africa CDC have urged an urgent, community-led expansion of early detection, testing, treatment access and frontline support while donors are pressed to speed funding and logistical resources; clinical trials and assessment of Ervebo for partial protection are being accelerated.
- Regional vigilance is high after more than 200 passengers on a quarantined river boat near Kinshasa tested negative and a suspected returning traveller in Israel is under investigation, underscoring cross-border export risks.